Anti-REV1抗体
Anti-REV1 antibody
4
(1 Review)
|
(4 Publications)
Goat Polyclonal REV1 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Synthetic Peptide within Human REV1 aa 1200 to C-terminus.
查看别名
REV1L, REV1, Translesion synthesis protein REV1, Alpha integrin-binding protein 80, Molecular adapter protein REV1, Rev1-like terminal deoxycytidyl transferase, Reversionless protein 1 homolog, Template-dependent deoxycytidyl transferase REV1, AIBP80, REV1 homolog
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-REV1 antibody (AB5088)
In paraffin embedded Human Testis shows nuclear staining in spermatogonia and spermatocytes. ab5088 used at 4ug/ml following Steamed antigen retrieval with Tris/EDTA buffer pH 9 visualised using HRP staining.
反应性数据
产品详情
性能和储存信息
形式
纯化工艺
纯化说明
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
REV1 operates within the context of DNA repair and a larger polymerase zeta complex working closely with other translesion DNA polymerases. REV1 interacts with other translesion synthesis proteins like POLH POLL and POLK to orchestrate the bypass of different types of DNA damage. These interactions enable REV1 to play a role in cellular responses to DNA damage and contribute to maintaining genome integrity.
Pathways
REV1 integrates into the DNA damage response and translesion synthesis pathways. In these pathways REV1 coordinates with REV3L and REV7 forming part of the polymerase zeta complex to process lesions bypass that regular DNA polymerases cannot handle. Significantly it associates with the Fanconi anemia pathway affecting DNA repair mechanisms under stress. These collaborations help manage replication stress and stabilize cellular division.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (4)
Recent publications for all applications. Explore the full list and refine your search
Oncology reports 54: PubMed40999956
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceuticals (Basel, Switzerland) 14: PubMed34959719
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed31936664
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 6:28587 PubMed27335258
2016
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com